Benefits of rituximab as a second-line treatment for autoimmune haemolytic anaemia in children: a prospective French cohort study
(1)
,
(2)
,
(3)
,
(4)
,
,
(5)
,
(6)
,
,
(7)
,
(8)
,
,
(9)
,
(10)
,
,
(11)
,
(12)
,
(13)
,
(14)
,
,
(15)
,
(16, 17)
,
(18)
,
(19)
,
(20)
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
Helder Fernandes
- Function : Author
- PersonId : 796800
- ORCID : 0000-0001-8932-4383
- IdRef : 097088293
Yves Bertrand
- Function : Author
- PersonId : 938340
Fabrice Monpoux
- Function : Author
Alain Fisher
- Function : Author
Fanny Fouissac
- Function : Author
Isabelle Pellier
- Function : Author
- PersonId : 992775
Philippe Vic
- Function : Author